Comparison of Outcomes Between Combined Sparing Laser Photocoagulation and Intravitreal Bevacizumab Treatment Versus Conventional Laser Photocoagulation in Aggressive Posterior Retinopathy of Prematurity

被引:4
作者
Ittarat, Mantapond [1 ,2 ]
机构
[1] Surin Hosp, Dept Ophthalmol, 68 Lak Muaeng Rd, Muaeng 32000, Surin, Thailand
[2] Suranaree Univ Technol, Sch Ophthalmol, Nakhon Ratchasima, Thailand
关键词
MANAGEMENT;
D O I
10.3928/01913913-20210316-01
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To report the clinical outcomes of combined sparing laser photocoagulation and intravitreal bevacizumab treatment compared to conventional laser photocoagulation for the treatment of aggressive posterior retinopathy of prematurity (APROP). Methods: A medical chart review was performed on all consecutive eyes with APROP that were treated with conventional laser photocoagulation or laser photocoagulation and intravitreal bevacizumab (IVB) injection between July 2019 and August 2020. The data were recorded for time to reversal of plus disease, time to total regression of retinopathy of prematurity (ROP) after intervention, total laser spots and area, proportion of eyes with satisfactory anatomical outcomes, and adverse events. Outcomes of the two groups were compared. Results: Sixteen eyes of 8 infants with APROP were included in the analysis. Eight eyes of 4 infants received combined sparing laser photocoagulation and IVB treatment, and 8 eyes of 4 infants received conventional laser photocoagulation. All 8 eyes in the combined treatment group and 6 of 8 eyes in the conventional treatment group showed regression of ROP with a satisfactory anatomical outcome. The average time to total regression of ROP was 34 days in the combined treatment group and 56 days in the conventional treatment group (P = .005). The number of laser spots was significantly lower in the combined treatment group (P= .03). Conclusions: Combined sparing laser photocoagulation and IVB treatment for eyes with APROP achieved ROP regression twice as fast, had fewer laser spots, and had a satisfactory anatomical outcome in comparison to conventional laser photocoagulation.
引用
收藏
页码:292 / 297
页数:6
相关论文
共 12 条
[1]   The international classification of retinopathy of prematurity revisited [J].
Gole, GA ;
Ells, AL ;
Katz, X ;
Holmstrom, G ;
Fielder, AR ;
Capone, A ;
Flynn, JT ;
Good, WG ;
Holmes, JM ;
McNamara, JA ;
Palmer, EA ;
Quinn, GE ;
Shapiro, MJ ;
Trese, MGJ ;
Wallace, DK .
ARCHIVES OF OPHTHALMOLOGY, 2005, 123 (07) :991-999
[2]  
Good William V, 2004, Trans Am Ophthalmol Soc, V102, P233
[3]  
Good WV, 2003, ARCH OPHTHALMOL-CHIC, V121, P1684
[4]  
Hartnett ME, 2012, NEW ENGL J MED, V367, P2515, DOI [10.1056/NEJMra1208129, 10.1056/NEJMc1301021]
[5]   Advances in understanding and management of retinopathy of prematurity [J].
Hartnett, Mary Elizabeth .
SURVEY OF OPHTHALMOLOGY, 2017, 62 (03) :257-276
[6]   Comparison of efficacy between anti-vascular endothelial growth factor (VEGF) and laser treatment in Type-1 and threshold retinopathy of prematurity (ROP) [J].
Li, Zijing ;
Zhang, Yichi ;
Liao, Yunru ;
Zeng, Rui ;
Zeng, Peng ;
Lan, Yuqing .
BMC OPHTHALMOLOGY, 2018, 18
[7]   Intravitreal ranibizumab monotherapy to treat retinopathy of prematurity zone II, stage 3 with plus disease [J].
Menke, Marcel N. ;
Framme, Carsten ;
Nelle, Mathias ;
Berger, Markus R. ;
Sturm, Veit ;
Wolf, Sebastian .
BMC OPHTHALMOLOGY, 2015, 15
[8]   Efficacy of Intravitreal Bevacizumab for Stage 3+Retinopathy of Prematurity. [J].
Mintz-Hittner, Helen A. ;
Kennedy, Kathleen A. ;
Chuang, Alice Z. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (07) :603-615
[9]   Retinal detachment of regressed retinopathy of prematurity in children aged 2 to 15 years [J].
Park, KH ;
Hwang, JM ;
Choi, MY ;
Yu, YS ;
Chung, H .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2004, 24 (03) :368-375
[10]  
Wu WC, 2017, RETINA-J RET VIT DIS, V37, P694, DOI 10.1097/IAE.0000000000001209